FindTrial
Sign In

Effect of Traditional Chinese Medicine on Preventing Recurrence and Metastasis in Patients with Colorectal Cancer

Effect of Traditional Chinese Medicine on Preventing Recurrence and Metastasis in Patients with Colorectal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036635
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

experimental group:Adjuvant Chemotherapy+traditional Chinese medicine
control group:Adjuvant Chemotherapy+placebo

Sponsors

Shuguang Hospital,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Pathologically confirmed with colorectal cancer who had undergone curative resection within 8 weeks; (2) the TCM syndromes accord with the deficiency of kidney essence; (3) stage III in TNM pathological staging according to the American Joint Committee on Cancer; (4) men or women aged from 18 to 80 years; (5) ECOG <= 2; (6) no strict heart, liver, kidney, or hematopoietic system disease or other factor affecting drug evaluation; (7) volunteers who had given informed consent.

Exclusion criteria

Exclusion criteria: (1) Mental disorder, pregnancy, or lactation; (2) participant in other clinical trial; (3) any adverse reaction to traditional Chinese medicine; (4) incomplete information.

Design outcomes

Primary

MeasureTime frame
DFS;—

Secondary

MeasureTime frame
quality of life;TCM syndrome score;—

Countries

China

Contacts

Public ContactQi Li

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

qili@shutcm.edu.cn+86 13918191899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026